Development of an artificial intelligence system to indicate intraoperative findings of scarring in laparoscopic cholecystectomy for cholecystitis
Surgical Endoscopy · 2025
DOI: 10.1007/s00464-024-11514-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgical Endoscopy, 2025. Verfasst von Hiroki Orimoto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Yufu, Oita, 879-5593, Japan. orihiro…. Hauptthemen laut MEDLINE: Cholecystectomy, Laparoscopic, Cicatrix, Artificial Intelligence, Cholecystitis, Acute. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Oita University.
Abstract (Originalsprache)
Background
The surgical difficulty of laparoscopic cholecystectomy (LC) for acute cholecystitis (AC) and the risk of bile duct injury (BDI) depend on the degree of fibrosis and scarring caused by inflammation; therefore, understanding these intraoperative findings is crucial to preventing BDI. Scarring makes it particularly difficult to perform safely and increases the BDI risk. This study aimed to develop an artificial intelligence (AI) system to indicate intraoperative findings of scarring in LC for AC. Materials and methods An AI system was developed to detect scarred areas using an algorithm for semantic segmentation based on deep learning. The training dataset consisted of 2025 images extracted from LC videos of 21 cases with AC. External evaluation committees (EEC) evaluated the AI system on 20 cases of untrained data from other centers. EECs evaluated the accuracy in identifying the scarred area and the usefulness of the AI system, which were assessed based on annotation and a 5-point Likert-scale questionnaire.
Results
The average DICE coefficient for scarred areas between AI detection and EEC annotation was 0.612. The EEC’s average detection accuracy on the Likert scale was 3.98 ± 0.76. AI systems were rated as relatively useful for both clinical and educational applications.
Conclusion
We developed an AI system to detect scarred areas in LC for AC. Since scarring increases the surgical difficulty, this AI system has the potential to reduce BDI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Yufu, Oita, 879-5593, Japan. orihiro@oita-u.ac.jp.
- Department of Gastroenterological and Pediatric Surgery, Faculty of Medicine, Oita University, 1-1 Hasama-Machi, Yufu, Oita, 879-5593, Japan.
- Department of Information System and Engineering, Faculty of Information Engineering, Fukuoka Institute of Technology, Fukuoka, Japan.
ORCID-Profile: Hiroki Orimoto
Förderung
- Oita University
Zitieren
APA
Orimoto, H., Hirashita, T., Ikeda, S., Amano, S., Kawamura, M., Kawano, Y., Takayama, H., Masuda, T., Endo, Y., Matsunobu, Y., Shinozuka, K., Tokuyasu, T., & Inomata, M. (2025). Development of an artificial intelligence system to indicate intraoperative findings of scarring in laparoscopic cholecystectomy for cholecystitis. Surgical Endoscopy. https://doi.org/10.1007/s00464-024-11514-2
Vancouver
Orimoto H, Hirashita T, Ikeda S, Amano S, Kawamura M, Kawano Y, et al. Development of an artificial intelligence system to indicate intraoperative findings of scarring in laparoscopic cholecystectomy for cholecystitis. Surgical Endoscopy. 2025. doi:10.1007/s00464-024-11514-2
BibTeX
@article{Orimoto2025,
author = {Orimoto, Hiroki and Hirashita, Teijiro and Ikeda, Subaru and Amano, Shota and Kawamura, Masahiro and Kawano, Yoko and Takayama, Hiroomi and Masuda, Takashi and Endo, Yuichi and Matsunobu, Yusuke and Shinozuka, Ken'ichi and Tokuyasu, Tatsushi and Inomata, Masafumi},
title = {Development of an artificial intelligence system to indicate intraoperative findings of scarring in laparoscopic cholecystectomy for cholecystitis},
journal = {Surgical Endoscopy},
year = {2025},
doi = {10.1007/s00464-024-11514-2}
}
EUVIMED